References
- McNally P G, Feehally J. Pathophysiology of cyclosporin A nephrotoxicity: experimental and clinical observations. Nephrol Dial Transplant 1992; 7: 791–804
- Randhawa P S, Shapiro R, Jordan M L, Starzl T E, Demetris A J. The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK 506. Am J Surg Pathol 1993; 17: 60–68
- Burdmann E A, Rosen S, Lindsley J, Elzinga L, Andoh T, Bennett W M. Cyclosporine G produces less chronic nephrotoxicity than cyclosporine A in a low salt rat model. Transplantation 1993, in press
- Andoh T F, Burdmann E A, Lindsley J, Houghton D C, Bennett W M. FK 506-induced nephrotoxicity in sodium-depleted rats. JASN 1992; 3: 719
- Bennett W M, Porter G A. Overview of clinical nephrotoxicity. Toxicology of the Kidney2nd ed, J B Hook, R S Goldstein. Raven Press, New York 1993; 61–97
- Price R G. Urinary enzymes, nephrotoxicity and renal disease. Toxicology 1982; 23: 99–134
- Bennett W M, Elzinga L W, Porter G A. Tubulointerstitial disease and toxic nephropathy. The Kidney4th ed, B M Brenner, F C Rector, Jr. WB Saunders, Philadelphia 1991; 1430–1496
- Lockwood T D, Bosmann H C. The use of urinary N-acetyl-β-glucosaminidase in human renal toxicology. I. partial biochemical characterization and excretion in humans and release from the isolated perfused rat kidney. Toxicol Appl Pharmacol 1979; 49: 323–336
- Lauwerys R R, Bernard A. Early detection of the nephrotoxic effects of industrial chemicals: state of the art and future prospects. Am J Ind Med 1987; 11: 275–285
- Mueller P W, MacNeil M L, Steinberg K K. Stabilization ol alanine aminopeptidase, gamma glutamyltranspeptidase, and N-acetyl-β-glucosaminidase activity in normal urines. Arch Environ Contam Toxicol 1986; 15: 343–347
- Jung K, Scholz D. An optimized assay of alanine aminopeptidase activity in urine. Clin Chem 1980; 26: 1251–1254
- Dubach U C, Hir M L. Critical evaluation of the diagnostic use of urinary enzymes. Contr Nephrol 1984; 42: 74–80
- Foulkes E C. Functional assessment of the kidney. Toxicology of the Kidney2nd ed, J B Hook, R S Goldstein. Raven Press, New York 1993; 37–60
- Stillman I E, Brezis M, Greenfeld Z, Ransil B J, Heyman S N, Rosen S. Cyclosporine nephropathy: morphometric analysis of the medullary thick ascending limb. Am J Kidney Dis 1992; 20: 162–167
- Plummer D T, Noorazar S, Obatomi D K, Haslam J D. Assessment of renal injury by urinary enzymes. Uremia Invest 1985–1986; 9: 97–102
- McAuley F T, Simpson J G, Thomson A W, Whiting P H. Cyclosporin A-induced nephrotoxicity in the rat: relationship to increased plasma renin activity. Agents and Actions 1987; 21: 209–216
- Guder W G, Ross B D. Enzyme distribution along the nephron. Kidney Int 1984; 26: 101–111
- Guder W G, Hofmann W. Future markers for the diagnosis of renal lesions. Nephrotoxicity, Mechanisms, Early Diagnosis and Therapeutic Management, P H Bach, N J Gregg, M F Wilks, L Delacruz. Dekker, New York 1991; 575–580
- Rosen S, Greenfeld Z, Brezis M. Chronic cyclosporine induced nephropathy in the rat. Transplantation 1990; 49: 44–452
- Stonard M D, Gore C W, Oliver G JA, Smith I K. Urinary enzymes and protein patterns as indicators of injury to different regions of the kidney. Fundam Appl Toxicol 1987; 9: 339–351
- Whiting P H, Thomson A W, Simpson J G. Cyclosporine and renal enzyme excretion. Clin Nephrol 1986; 25(suppl.1)S100–4104